HOME >> BIOLOGY >> NEWS
Bayer HealthCare licenses Genomatix for microarray analysis

Genomatix announced today that Bayer HealthCare licensed Genomatix microarray analysis platform ChipInspector. ChipInspector enables biologists and bio-informaticians to analyze chip raw data from Affymetrix GeneChip and Exon Arrays. It employs a proprietary single probe approach based on latest genomic annotation from Genomatix ElDorado annotation pipeline. Starting with ChipInspector the Genomatix Microarray Analysis Pipeline integrates literature and pathway mining as well as promoter analysis on sequence level in one coherent system.

"After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector. We expect that ChipInspector will enhance the Affymetrix analysis pipeline starting from GeneChip and Exon Arrays at Bayer" states Dr. Martin Seifert, VP Microarray business and collaborative research.


'"/>

Contact: Klaus May
may@genomatix.de
49-89-599-7660
Genomatix Software GmbH
22-May-2006


Page: 1

Related biology news :

1. TB Alliance and Bayer launch historic global drug trials for tuberculosis
2. Bayer donates equipment to Childrens Hospital, Oakland for infectious disease research
3. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
4. Rensselaer licenses microscope technology to Thorlabs
5. Columbia University licenses next-generation DNA sequencing technology
6. Case Western Reserve University licenses methoxyamine to Tracon
7. Yale licenses potential anti-HIV agent to Oncolys BioPharma of Japan
8. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
9. Isotron licenses ORNL cancer treatment technology
10. IC-medtech licenses promising cancer therapeutic from Summa Health System
11. Genomatix expands operations in North America

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... Dec. 15, 2016 Advancements in ... health wellness and wellbeing (HWW), and security ... three new passenger vehicles begin to feature ... recognition, heart beat monitoring, brain wave monitoring, ... monitoring, and pulse detection. These will be ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the growth of ... expected to grow from USD 4.03 billion in 2015 ... of 29.3% between 2016 and 2022. The market is ... smart devices, government initiatives, and increasing penetration of e-commerce ... to grow at a high rate during the forecast ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., today ... , Ph.D., as chief executive officer, as well ... Dr. Schmidt brings to ArmaGen more than 17 years ... and development of biotherapeutics and pharmaceuticals. ... the diverse experience and skillset necessary to lead ...
(Date:1/19/2017)... Minneapolis, Minnesota (PRWEB) , ... January 19, 2017 ... ... contract research organization with services spanning the full spectrum of drug and device ... clinical research services to pharma/device companies and clinicians, today announced Verified Clinical ...
(Date:1/18/2017)... ... 2017 , ... Opal Kelly, a leading producer of powerful ... the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 interface and ... suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface delivers real-world ...
Breaking Biology Technology:
Cached News: